Literature DB >> 18220733

Oxidative RNA damage and neurodegeneration.

A Nunomura1, P I Moreira, A Takeda, M A Smith, G Perry.   

Abstract

Although cellular RNA should be subject to the same oxidative insults as DNA and other cellular macromolecules, oxidative damage to RNA has not been a major focus in investigating the magnitude and the biological consequences of the free radical damage. However, because RNA is mostly single-stranded and its bases are not protected by hydrogen bonding and are less protected by specific proteins, RNA may be more susceptible to oxidative insults than DNA. Thereafter, oxidative damage to protein-coding RNA or non-coding RNA will potentially cause errors in proteins or dysregulation of gene expression. While less lethal than mutations in genome, such non-acutely lethal insults to cells might be associated with underlying mechanisms of several human diseases, especially chronic degeneration. Recently, oxidative RNA damage has been described in several neurodegenerative diseases including Alzheimer disease, Parkinson disease, dementia with Lewy bodies, and prion diseases. Of particular interest, oxidative RNA damage is a feature in vulnerable neurons at the very earliest-stages of these diseases, suggesting that RNA oxidation may actively contribute to the onset or to the development of disease. Mechanistically speaking, an increasing body of evidence suggests that the detrimental effects of oxidative RNA damage to protein synthesis are attenuated, at least in part, by the existence of mechanisms that avoid the incorporation of the damaged ribonucleotides into the translational machinery. Further investigations toward understanding of the consequences and processing mechanisms related to oxidative RNA damage may provide significant insights into the pathogenesis and therapeutic strategies for neurodegenerative and other degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220733     DOI: 10.2174/092986707782794078

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  34 in total

Review 1.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 2.  Neuroprotective strategies involving ROS in Alzheimer disease.

Authors:  Magali Dumont; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2010-12-01       Impact factor: 7.376

3.  Polynucleotide phosphorylase protects Escherichia coli against oxidative stress.

Authors:  Jinhua Wu; Zhe Jiang; Min Liu; Xin Gong; Shaohui Wu; Christopher M Burns; Zhongwei Li
Journal:  Biochemistry       Date:  2009-03-10       Impact factor: 3.162

4.  Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

Authors:  Milos D Ikonomovic; Eric E Abrahamson; Tolga Uz; Hari Manev; Steven T Dekosky
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

5.  Intrastrand G-U cross-links generated by the oxidation of guanine in 5'-d(GCU) and 5'-r(GCU).

Authors:  Conor Crean; Nicholas E Geacintov; Vladimir Shafirovich
Journal:  Free Radic Biol Med       Date:  2008-07-23       Impact factor: 7.376

6.  Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal.

Authors:  Kirill Tsirulnikov; Natalia Abuladze; Anatol Bragin; Kym Faull; Duilio Cascio; Robert Damoiseaux; Matthew J Schibler; Alexander Pushkin
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-20       Impact factor: 4.219

Review 7.  Quality control of chemically damaged RNA.

Authors:  Carrie L Simms; Hani S Zaher
Journal:  Cell Mol Life Sci       Date:  2016-05-07       Impact factor: 9.261

8.  Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts.

Authors:  Gaetan Deslee; Tracy L Adair-Kirk; Tomoko Betsuyaku; Jason C Woods; Carla H Moore; David S Gierada; Susan H Conradi; Jeffrey J Atkinson; Holly M Toennies; John T Battaile; Dale K Kobayashi; G Alexander Patterson; Michael J Holtzman; Richard A Pierce
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

9.  Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease.

Authors:  Magali Dumont; Elizabeth Wille; Noel Y Calingasan; Davide Tampellini; Charlotte Williams; Gunnar K Gouras; Karen Liby; Michael Sporn; Carl Nathan; M Flint Beal; Michael T Lin
Journal:  J Neurochem       Date:  2009-02-07       Impact factor: 5.372

Review 10.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.